Year |
Citation |
Score |
2015 |
Incrocci R, Hussain S, Stone A, Bieging K, Alt LA, Fay MJ, Swanson-Mungerson M. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Cellular Immunology. PMID 26255694 DOI: 10.1016/J.Cellimm.2015.08.001 |
0.425 |
|
2015 |
Bieging KT, Attardi LD. A piece of the p53 puzzle Nature. 520: 37-38. PMID 25799989 DOI: 10.1038/Nature14374 |
0.398 |
|
2015 |
Jiang D, LaGory EL, Kenzelmann Brož D, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Reports. 10: 1096-109. PMID 25704813 DOI: 10.1016/J.Celrep.2015.01.043 |
0.467 |
|
2014 |
Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer. 14: 359-370. PMID 24739573 DOI: 10.1038/Nrc3711 |
0.395 |
|
2013 |
Kenzelmann Broz D, Mello SS, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses Genes and Development. 27: 1016-1031. PMID 23651856 DOI: 10.1101/Gad.212282.112 |
0.456 |
|
2013 |
Brägelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, Zuo Z, Khattri A, Keck M, McNerney ME, Longnecker R, Bieging K, Kocherginsky M, Alexander K, Salgia R, Lingen MW, et al. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49: 525-33. PMID 23490885 DOI: 10.1016/J.Oraloncology.2013.02.003 |
0.502 |
|
2013 |
Brady CA, Broz DK, Jiang D, Mello SS, Bieging K, Johnson TM, Jarvis LA, Kozak MM, Basak S, Attardi LD. Abstract IA4: Deconstructing p53 pathways in vivo Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia4 |
0.491 |
|
2012 |
Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression Trends in Cell Biology. 22: 97-106. PMID 22154076 DOI: 10.1016/J.Tcb.2011.10.006 |
0.538 |
|
2011 |
Bieging KT, Fish K, Bondada S, Longnecker R. A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma. Blood. 118: 6849-59. PMID 22039254 DOI: 10.1182/Blood-2011-02-338434 |
0.582 |
|
2010 |
Bieging KT, Swanson-Mungerson M, Amick AC, Longnecker R. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle (Georgetown, Tex.). 9: 901-8. PMID 20160479 DOI: 10.4161/Cc.9.5.10840 |
0.608 |
|
2009 |
Bieging KT, Amick AC, Longnecker R. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 17945-50. PMID 19815507 DOI: 10.1073/Pnas.0907994106 |
0.633 |
|
2009 |
Bieging KT, Amick AC, Longnecker R. Abstract B30: EBV LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B30 |
0.571 |
|
Show low-probability matches. |